IRENE BAYER: Open Payments
NPI 1578995288 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,648 in 87 payments from 12 companies in 2025. Trend: 2023 $1,379 · 2024 $2,524 · 2025 $1,648
Food & beverage: $1,351Education: $297
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 28 | $449 |
| UCB, Inc. | 19 | $364 |
| ABBVIE INC. | 21 | $298 |
| GENZYME CORPORATION | 4 | $149 |
| Arcutis Biotherapeutics, Inc. | 5 | $102 |
| SANOFI-AVENTIS U.S. LLC | 1 | $97 |
| Galderma Laboratories, L.P. | 2 | $47 |
| PFIZER INC. | 2 | $46 |
| Lilly USA, LLC | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $33 |
Products named: TREMFYA, Bimzelx, RINVOQ, DUPIXENT, SKYRIZI, Zoryve, NEMLUVIO, CIBINQO.
Industry payments across WA — which companies pay providers there.
